Lymphopenia is ubiquitous in COVID-19 patients with significantly decreased absolute counts of T-cells, and increased levels of pro-inflammatory cytokines (e.g. IFN-γ, IL-6, IL-8) [43,44]. The gene discussed is IFNG; the disease is COVID-19.